Friday, January 02, 2026 | 09:08 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Several new drugs being developed under the AYUSH system of medicine: Shri Shripad Naik

Image

Delhi
Several new drugs being developed under the AYUSH system of medicine: Shri Shripad Naik


Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central Council for Research in Homoeopathy (CCRH) has developed 9 drugs out of which 2 are of vegetable origin, 5 are from different strains of Dengue virus and two are of chemical origin. Central Council for Research in Siddha (CCRS) has developed D-5 choornam for the management of Type II Diabetes. In addition Ministry of AYUSH through its Research Councils has undertaken R&D for development of new AYUSH drugs with details as under:-

 

Ayurveda
1. Ayush-QOL RC for improvement of quality of life in cancer patients
2. Ayush- Manas for Mental retardation in Children
3. C-1 oil for wound healing
 
4. Ayush- Rasayan – A&B for Geriatric Health,
 
5. Ayush – D for Diabetes,
6. Ayush – A for Asthma,
7. Ayush – PJ – 7 for Dengue

Unani


            The Central Council for Research in Unani Medicine (CCRUM) has conducted multi – centric clinical trials on four new Unani formulations on Vitiligo, Diabetes Mellitus type – II, Essential Hypertension and Infective Hepatitis. Experimental safety of these drugs has already been established.
 

              The development of new drugs is a standard procedure which involves standardization of raw drug followed by Drug proving, Clinical Verification and Clinical Trial and the whole process takes 7 to 8 years or even more. 

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Lok Sabha today.

 

NB/SK

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 31 2017 | 8:20 PM IST

Explore News